Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moupali Das

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Plos One|June 16, 2010
Decreases in community viral load are accompanied by reductions in new HIV infections in San FranciscoMoupali Das, Priscilla Lee Chu, Glenn-Milo Santos, et al.
AIDS (London, England)|April 17, 2010
Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with menMoupali Das, Deirdre Santos, Tim Matheson, et al.
AIDS and Behavior|May 17, 2008
Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptionsMoupali Das-Douglas, Elise D Riley, Kathleen Ragland, et al.
Plos One|July 31, 2008
Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levelsJean-Jacques Parienti, Moupali Das-Douglas, Véronique Massari, et al.
Archives of General Psychiatry|November 9, 2011
Mirtazapine to reduce methamphetamine use: a randomized controlled trialGrant N Colfax, Glenn-Milo Santos, Moupali Das, et al.
Plos One|February 29, 2020
Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weightCarrie McMahon, James L Trevaskis, Christoph Carter, et al.
Journal of the International AIDS Society|May 22, 2021
Using the adherence-efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trialDavid V Glidden, Moupali Das, David T Dunn, et al.
Plos One|December 12, 2019
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarateLinn Hermansson, Aylin Yilmaz, Richard W Price, et al.
Addiction (Abingdon, England)|November 29, 2012
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trialPhillip Oliver Coffin, Glenn-Milo Santos, Moupali Das, et al.
Open Forum Infectious Diseases|January 18, 2020
Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil FumarateGregory D Huhn, David J Shamblaw, Jean-Guy Baril, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Plos One|June 16, 2010
Decreases in community viral load are accompanied by reductions in new HIV infections in San FranciscoMoupali Das, Priscilla Lee Chu, Glenn-Milo Santos, et al.
AIDS (London, England)|April 17, 2010
Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with menMoupali Das, Deirdre Santos, Tim Matheson, et al.
AIDS and Behavior|May 17, 2008
Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptionsMoupali Das-Douglas, Elise D Riley, Kathleen Ragland, et al.
Plos One|July 31, 2008
Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levelsJean-Jacques Parienti, Moupali Das-Douglas, Véronique Massari, et al.
Archives of General Psychiatry|November 9, 2011
Mirtazapine to reduce methamphetamine use: a randomized controlled trialGrant N Colfax, Glenn-Milo Santos, Moupali Das, et al.
Plos One|February 29, 2020
Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weightCarrie McMahon, James L Trevaskis, Christoph Carter, et al.
Journal of the International AIDS Society|May 22, 2021
Using the adherence-efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trialDavid V Glidden, Moupali Das, David T Dunn, et al.
Plos One|December 12, 2019
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarateLinn Hermansson, Aylin Yilmaz, Richard W Price, et al.
Addiction (Abingdon, England)|November 29, 2012
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trialPhillip Oliver Coffin, Glenn-Milo Santos, Moupali Das, et al.
Open Forum Infectious Diseases|January 18, 2020
Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil FumarateGregory D Huhn, David J Shamblaw, Jean-Guy Baril, et al.
Pageof 7